ECSP088317A - PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF INTERNAL EAR DISORDERS - Google Patents

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF INTERNAL EAR DISORDERS

Info

Publication number
ECSP088317A
ECSP088317A ECSP088317A ECSP088317A EC SP088317 A ECSP088317 A EC SP088317A EC SP088317 A ECSP088317 A EC SP088317A EC SP088317 A ECSP088317 A EC SP088317A
Authority
EC
Ecuador
Prior art keywords
treatment
pharmaceutical compositions
internal ear
ear disorders
compositions
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Thomas Meyer
Original Assignee
Auris Medical Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Auris Medical Ag filed Critical Auris Medical Ag
Priority to ECSP088317 priority Critical patent/ECSP088317A/en
Publication of ECSP088317A publication Critical patent/ECSP088317A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención proporciona composiciones que contienen (i) un principio activo farmacéutico seleccionado de entre el grupo consistente en arilcicloalquilaminas o derivados, análogos o sales farmacéuticamente activas de las mismas, y (ii) un polímero biocompatible o una combinación de polímeros biocompatibles. Estas composiciones o los medicamentos que las contienen se pueden utilizar para la prevención y/o el tratamiento de enfermedades del oído interno, por ejemplo tinnitus.The present invention provides compositions containing (i) a pharmaceutical active ingredient selected from the group consisting of arylcycloalkylamines or pharmaceutically active derivatives, analogs or salts thereof, and (ii) a biocompatible polymer or a combination of biocompatible polymers. These compositions or the medications containing them can be used for the prevention and / or treatment of diseases of the inner ear, for example tinnitus.

ECSP088317 2008-03-27 2008-03-27 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF INTERNAL EAR DISORDERS ECSP088317A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP088317 ECSP088317A (en) 2008-03-27 2008-03-27 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF INTERNAL EAR DISORDERS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP088317 ECSP088317A (en) 2008-03-27 2008-03-27 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF INTERNAL EAR DISORDERS

Publications (1)

Publication Number Publication Date
ECSP088317A true ECSP088317A (en) 2008-05-30

Family

ID=40434925

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP088317 ECSP088317A (en) 2008-03-27 2008-03-27 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF INTERNAL EAR DISORDERS

Country Status (1)

Country Link
EC (1) ECSP088317A (en)

Similar Documents

Publication Publication Date Title
BRPI0520588A2 (en) pharmaceutical compositions for the treatment of inner ear disorders
GT200600028A (en) COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF PROTEINA KINASA
CO6491060A2 (en) COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITARY DISEASES
CL2019002745A1 (en) Substituted indoline derivatives as dengue virus replication inhibitors.
ECSP12012171A (en) PHARMACEUTICAL COMPOSITIONS OF THE ESPIRO-OXINDOL COMPOUND FOR TOPICAL ADMINISTRATION AND ITS USES AS THERAPEUTIC AGENTS
CL2019002744A1 (en) Substituted indoline derivatives as dengue virus replication inhibitors.
MX2015008396A (en) 2,3-dihydro-isoindole-1-on derivative as btk kinase suppressant, and pharmaceutical composition including same.
BR112015029512A8 (en) pyrazolopyrrolidine derivatives, their uses, and pharmaceutical composition and combination
MX2019013878A (en) Substituted indoline derivatives as dengue viral replication inhibitors.
ECSP18073366A (en) INDOLINE DERIVATIVES SUBSTITUTE AS INHIBITORS OF DENGUE VIRAL REPLICATION
MX2018011785A (en) INDOLINA DERIVATIVES REPLACED AS INHIBITORS OF THE VIRAL REPLICATION OF DENGUE.
MX2019013893A (en) INDOLINE DERIVATIVES SUBSTITUTED AS INHIBITORS OF THE VIRIC REPLICATION OF DENGUE.
BR112015029401A8 (en) pyrazolo-pyrrolidin-4-one derivatives, their uses, and pharmaceutical composition and combination
BR112013026257A2 (en) glycoside derivatives and uses thereof for the treatment of diabetes
MX2015009269A (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE NITROXYL DONORS.
MX2021012904A (en) Modulators of the integrated stress response pathway.
UY38912A (en) COMPLEMENT FACTOR D INHIBITORS FOR ORAL ADMINISTRATION
CL2011002766A1 (en) Carboxamide derived compounds, calpain inhibitors; pharmaceutical composition comprising them; and its use in the treatment of neurodegenerative diseases, alzahimer, pain, among others.
CO2022005926A2 (en) Complement factor d inhibitors for oral administration
CL2007002875A1 (en) Pharmaceutical composition covered by a film comprising capecitabine and at least one disintegrant, useful in the treatment of cancer for patients who have difficulty swallowing oral solid dosage forms.
MX2021015654A (en) Ep2 antagonist.
BR112016026552A8 (en) carboxamide derivatives, their uses, pharmaceutical composition, and combination
EA202191684A1 (en) DRUG CONTAINING URSODEOXYCHOLIC ACID FOR TREATMENT OR PREVENTION OF PRESBIOPIA
MX2022005234A (en) Isoquinolinone derivative, preparation method therefor, and pharmaceutical composition, comprising same as active ingredient, for prevention or treatment of poly(adp-ribose)polym erase-1 (parp-1)-associated disease.
MX2022005650A (en) THERAPEUTIC AGENT AND PROPHYLACTIC AGENT FOR FUNCTIONAL GASTROINTESTINAL DISORDERS AND XEROSTOMIA.